Abstract
In man a great interindividual variability exists in the oxidative capacity to metabolize drugs. A major factor contributing to this phenomenon is the genetically determined hydroxylation-capacity of the cytochrome P450 enzyme system. The cytochrome P450 system comprises of several isozymes. For several isozymes (CYP2D6, CYP2C) a genetically based hydroxylation capacity has been demonstrated. A frequency distribution of the clearance shows a bimodal distribution with poor and extensive metabolizers. Applying standard dosing schemes of the drugs that are predominantly metabolised by these isozymes, a considerable number of patients will be intoxicated because of poor metabolism. In general, cytochrome P450 capacity is limited and substrate-affinity is high. Henceforth cytochrome P450 isozymes are likely targets for pharmacokinetic interactions.
Translated title of the contribution | The cytochrome p450 enzyme system: What is its relevance for the practice |
---|---|
Original language | Dutch |
Pages (from-to) | 34-42 |
Number of pages | 9 |
Journal | Acta Neuropsychiatrica |
Volume | 10 |
Issue number | 2 |
Publication status | Published - 16-Jun-1998 |
Keywords
- cytochrome P450
- cytochrome P450 isoenzyme
- enzyme polymorphism
- enzyme substrate complex
- human
- hydroxylation
- review
- xenobiotic metabolism